Biotech News

iRhythm Holdings to Report Second Quarter 2026 Financial Results on August 6, 2026

iRhythm (IRTC)iRhythmEarnings

iRhythm Holdings, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that it will release financial results for the second quarter 2026 after the close of trading on Thursday, August 6, 2026. The company’s management team will host a corresponding conference call beginning at 1:30 p.m. PT / 4:30 p.m. ET.

Interested parties may access a live and archived webcast of the conference call on the “Quarterly Results” section of the company’s investor website at investors.irhythmtech.com .

About iRhythm Holdings, Inc. iRhythm is a leading digital health care company that creates trusted solutions that detect, predict, and prevent disease. Combining wearable biosensors and cloud-based data analytics with powerful proprietary algorithms, iRhythm distills data from millions of heartbeats into clinically actionable information. Through a relentless focus on patient care, iRhythm’s vision is to deliver better data, better insights, and better health for all.

Investor Contact investors@irhythmtech.com

Media Contact Kassandra Perry mediarelations@irhythmtech.com

Related news

iRhythm

iRhythm is a cardiac monitoring company best known for its Zio patch and ambulatory arrhythmia analysis platform.

Recent company news

Stock data

Close
112.15 USD
Market cap
3.47B USD
Exchange
NASDAQ
Sector
MedTech
Location
United States